Skip to main content
PMC home page
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1977;70(Suppl 9):144–147.

Pharmacokinetic Studies of Cefuroxime and Dosage Recommendations in Patients with Impaired Renal Function

D Höffler, M Sassmann
PMCID: PMC1543240  PMID: 20919392

Full text

PDF
146

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Heinecke G., Höffler U., Finke K. Reversible encephalopathy following cephacetril therapy in high doses in a patient on chronic intermittent hemodialysis. Clin Nephrol. 1976 Jan;5(1):45–47. [PubMed] [Google Scholar]
  2. Höffler D., Koeppe P., Fuchs E., Fiegel P. Cephalothin-Plasmaspiegel bei normaler und eingeschränkter Nierenfunktion. Int Z Klin Pharmakol Ther Toxikol. 1972 Feb;5(4):450–459. [PubMed] [Google Scholar]
  3. Perkins R. L., Apicella M. A., Lee I. S., Cuppage F. E., Saslaw S. Cephaloridine and cephalothin: comparative studies of potential nephrotoxicity. J Lab Clin Med. 1968 Jan;71(1):75–84. [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES